These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11236810

  • 21. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation.
    Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K.
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):479-84. PubMed ID: 11699612
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology.
    Valdivieso N, Oteo I, Valdivieso A, Lukas JC, Leal N, Gastaca M, de Urbina JO, Calvo R, Suarez E.
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):606-14. PubMed ID: 23735178
    [Abstract] [Full Text] [Related]

  • 23. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S, Praisuwan S, Techawathanawanna N, Treyaprasert W, Avihingsanon Y.
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [Abstract] [Full Text] [Related]

  • 24. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
    Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL.
    Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
    [Abstract] [Full Text] [Related]

  • 25. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
    Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Inui K.
    Clin Pharmacol Ther; 2006 Oct; 80(4):331-45. PubMed ID: 17015051
    [Abstract] [Full Text] [Related]

  • 26. Total plasma protein effect on tacrolimus elimination in kidney transplant patients--population pharmacokinetic approach.
    Golubović B, Vučićević K, Radivojević D, Kovačević SV, Prostran M, Miljković B.
    Eur J Pharm Sci; 2014 Feb 14; 52():34-40. PubMed ID: 24184751
    [Abstract] [Full Text] [Related]

  • 27. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
    Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S.
    Eur J Clin Pharmacol; 2005 Jul 14; 61(5-6):409-16. PubMed ID: 15991041
    [Abstract] [Full Text] [Related]

  • 28. Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection.
    Darley DR, Carlos L, Hennig S, Liu Z, Day R, Glanville AR.
    Eur J Clin Pharmacol; 2019 Jul 14; 75(7):879-888. PubMed ID: 30859243
    [Abstract] [Full Text] [Related]

  • 29. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A, Tredger JM, Heneghan M, Agarwal K, Samyn M, Heaton ND, O'Grady JG, Aluvihare VR.
    Liver Transpl; 2015 Jan 14; 21(1):29-37. PubMed ID: 25312292
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation.
    Jacobo-Cabral CO, García-Roca P, Romero-Tejeda EM, Reyes H, Medeiros M, Castañeda-Hernández G, Trocóniz IF.
    Br J Clin Pharmacol; 2015 Oct 14; 80(4):630-41. PubMed ID: 25846845
    [Abstract] [Full Text] [Related]

  • 32. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y, Yang M, Sun Y, Li J, Lu Y, Li X.
    Eur J Hosp Pharm; 2020 Mar 14; 27(e1):e12-e18. PubMed ID: 32296499
    [Abstract] [Full Text] [Related]

  • 33. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID, Kelly DA.
    Paediatr Drugs; 2001 Mar 14; 3(1):43-60. PubMed ID: 11220404
    [Abstract] [Full Text] [Related]

  • 34. Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients.
    Chen L, Lu X, Tan G, Zhu L, Liu Y, Li M.
    Xenobiotica; 2020 Feb 14; 50(2):186-191. PubMed ID: 30995884
    [Abstract] [Full Text] [Related]

  • 35. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
    Staatz CE, Tett SE.
    Clin Pharmacokinet; 2004 Feb 14; 43(10):623-53. PubMed ID: 15244495
    [Abstract] [Full Text] [Related]

  • 36. Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.
    Ben Fredj N, Woillard JB, Debord J, Chaabane A, Boughattas N, Marquet P, Saint-Marcoux F, Aouam K.
    Exp Clin Transplant; 2016 Aug 14; 14(4):394-400. PubMed ID: 27506258
    [Abstract] [Full Text] [Related]

  • 37. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction.
    Oteo I, Lukas JC, Leal N, Suarez E, Valdivieso A, Gastaca M, Ortiz de Urbina J, Calvo R.
    Eur J Clin Pharmacol; 2013 Jan 14; 69(1):65-74. PubMed ID: 22660442
    [Abstract] [Full Text] [Related]

  • 38. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation.
    Oteo I, Lukas JC, Leal N, Suarez E, Valdivieso A, Gastaca M, de Urbina JO, Calvo R.
    Eur J Clin Pharmacol; 2011 Jul 14; 67(7):671-9. PubMed ID: 21327908
    [Abstract] [Full Text] [Related]

  • 39. Hemoglobin and total bilirubin may affect tacrolimus clearance in liver transplant patient following the early postoperative period: a case report.
    Tharanon V, Iamrahong P, Tuamsem J, Choochaeam K, Auamnoy T, Sobhonslidsuk A.
    J Med Case Rep; 2024 Sep 05; 18(1):408. PubMed ID: 39232822
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
    del Mar Fernández De Gatta M, Santos-Buelga D, Domínguez-Gil A, García MJ.
    Clin Pharmacokinet; 2002 Sep 05; 41(2):115-35. PubMed ID: 11888332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.